Indian hospital equities emerged as Dalal Street's top performers, posting an impressive rally of up to 14% over five consecutive trading sessions. Market heavyweights—including Max Healthcare, Fortis Healthcare, Apollo Hospitals, and Aster DM Quality Care—logged sustained gains driven by robust corporate earnings optimism and expanding operational capacity.
Leading brokerages have reiterated 'Buy' ratings on Apollo, Fortis, and Max Healthcare, citing compelling long-term fundamentals, improving average revenue per occupied bed (ARPOB), and disciplined capital expenditure. As demographic tailwinds and health insurance penetration bolster institutional demand, the healthcare sector continues to offer defensive yet high-growth opportunities for equity investors.




